Hemogenyx Pharmaceuticals PLC
HEMO
Company Profile
Business description
Hemogenyx Pharmaceuticals PLC is a clinical-stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune diseases and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. The company is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.
Contact
6 Heddon Street
LondonW1B 4BT
GBRSector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
16
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,529.80 | 9.60 | 0.11% |
| CAC 40 | 7,821.15 | 15.64 | -0.20% |
| DAX 40 | 23,518.92 | 8.09 | -0.03% |
| Dow JONES (US) | 42,051.06 | 89.37 | -0.21% |
| FTSE 100 | 8,603.52 | 18.51 | 0.22% |
| HKSE | 23,453.16 | 187.49 | -0.79% |
| NASDAQ | 19,146.81 | 136.72 | 0.72% |
| Nikkei 225 | 37,755.51 | 372.62 | -0.98% |
| NZX 50 Index | 12,880.82 | 101.56 | 0.79% |
| S&P 500 | 5,892.58 | 6.03 | 0.10% |
| S&P/ASX 200 | 8,297.50 | 17.90 | 0.22% |
| SSE Composite Index | 3,380.82 | 23.13 | -0.68% |